The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Accuray
Research Funding - Accuray
Five-fraction stereotactic body radiotherapy (SBRT) in concert with chemotherapy for treatment of inoperable pancreatic adenocarcinoma.
 
Christen R Elledge
No Relationships to Disclose
 
Jonathan W. Lischalk
No Relationships to Disclose
 
Marie Kate Gurka
No Relationships to Disclose
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera
Honoraria - Caris Life Sciences; Celgene; Sirtex Medical
Consulting or Advisory Role - Caris Life Sciences; Celgene; Perthera; Sirtex Medical
Research Funding - Celldex (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Perthera; Sirtex Medical
 
Brandon George Smaglo
No Relationships to Disclose
 
Aiwu Ruth He
No Relationships to Disclose
 
John Marshall
Honoraria - Amgen; Bayer/Onyx; Boehringer Ingelheim; Daiichi Sankyo; Genentech/Roche
Consulting or Advisory Role - Amgen; Bayer/Onyx; Boehringer Ingelheim; Daiichi Sankyo; Genentech/Roche
Speakers' Bureau - Amgen; Bayer/Onyx; Genentech/Roche
Research Funding - Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); MedImmune (Inst); Pfizer (Inst)
 
Sean P. Collins
No Relationships to Disclose
 
Keith Robert Unger
No Relationships to Disclose